Abstract:Introduction: Progranulin (PGRN) is a secreted glycoprotein, the expression of which is linked to several neurodegenerative diseases. Although its specific function is still unclear, several studies have linked it with lysosomal functions and immune system regulation. Here, we have explored the role of PGRN in peripheral and central immune system homeostasis by investigating the consequences of PGRN deficiency on adaptive and innate immune cell populations. Methods: First, we used gene co-expression network analysis of published data to test the hypothesis that Grn has a critical role in regulating the activation status of immune cell populations in both central and peripheral compartments. To investigate the extent to which PGRN-deficiency resulted in immune dysregulation, we performed deep immunophenotyping by flow cytometry of 19-24-month old male and female Grn-deficient mice (PGRN KO) and littermate Grn-sufficient controls (WT). Results: Male PGRN KO mice exhibited a lower abundance of microglial cells with higher MHC-II expression, increased CD44 expression on monocytes in the brain, and more CNS-associated CD8+ T cells compared to WT mice. Furthermore, we observed an increase in CD44 on CD8+ T cells in the peripheral blood. Female PGRN KO mice also had fewer microglia compared to WT mice, and we also observed reduced expression of MHC-II on brain monocytes. Additionally, we found an increase in Ly-6Chigh monocyte frequency and decreased CD44 expression on CD8+ and CD4+ T cells in PGRN KO female blood. Given that Gpnmb, which encodes for the lysosomal protein Glycoprotein non-metastatic melanoma protein B, has been reported to be upregulated in PGRN KO mice, we investigated changes in GPNMB protein expression associated with PGRN deficits and found that GPNMB is modulated in myeloid cells in a sex-specific manner. Discussion: Our data suggest that PGRN and GPNMB jointly regulate the peripheral and the central immune system in a sex-specific manner; thus, understanding their associated mechanisms could pave the way for developing new neuroprotective strategies to modulate central and peripheral inflammation to lower risk for neurodegenerative diseases and possibly delay or halt progression.

Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion

PGRN inhibits CD8+T cell recruitment and promotes breast cancer progression by up-regulating ICAM-1 on TAM

Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment.

Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer

The role of progranulin in macrophages of a glioblastoma model

Deciphering the potential role of PGRN in regulating CD8 + T cell antitumor immunity

Knock-down of Tumor-derived Progranulin Inhibits Grafted Melanoma Growth in C57BL/6J Mice

PGRN exacerbates the progression of non-small cell lung cancer via PI3K/AKT/Bcl-2 antiapoptotic signaling

PGR-KITLG Signaling Drives a Tumor-Mast Cell Regulatory Feedback to Modulate Apoptosis of Breast Cancer Cells

Dysregulation of the Mitogen Granulin in Human Cancer Through the Mir-15/107 Microrna Gene Group.

Progranulin Facilitates Conversion and Function of Regulatory T Cells under Inflammatory Conditions

Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways

Progranulin in Regulation Mechanism of Glycolipid Metabolism and Renal Disease

Growth Factor Progranulin Promotes Tumorigenesis of Cervical Cancer Via PI3K/Akt/mTOR Signaling Pathway

Progesterone receptor impairs immune respond and down-regulates sensitivity to anti-LAG3 in breast cancer

PGRN Promotes Migration and Invasion of Epithelial Ovarian Cancer Cells Through an Epithelial Mesenchymal Transition Program and the Activation of Cancer Associated Fibroblasts.

Progranulin Induces Adipose Insulin Resistance and Autophagic Imbalance Via TNFR1 in Mice.

PTGR1-mediated immune evasion mechanisms in late-stage triple-negative breast cancer: mechanisms of M2 macrophage infiltration and CD8+ T cell suppression

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance

Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system

Increased Expression of Progesterone Receptor Membrane Component 1 is Associated with Aggressive Phenotype and Poor Prognosis in ER-positive and Negative Breast Cancer.